Dezaguanine mesylate: a new antipurine antimetabolite W. R. LeopoldD. W. FryR. C. Jackson New Agent Review Pages: 223 - 231
Synergistic combination of menogarol and melphalan and other two drug combinations B. K. BhuyanE. G. AdamsS. L. Crampton Preclinical Studies Pages: 233 - 244
Mitotic arrest and interphase inhibition induced by the pyrimidine sulfoxide NY 4138 E. O. PettersenO. NomeR. Oftebro Preclinical Studies Pages: 245 - 253
Survival of L1210 leukemia cells and normal hematopoietic stem cells following in vivo administration of cyclocytidine Fred ValerioteIngomar D. MuntzTeresa J. Vietti Preclinical Studies Pages: 255 - 261
Distribution, elimination, metabolism and bioavailability of hexamethylenebisacetamide in rats Charles L. LitterstJeri S. RothJames A. Kelley Preclinical Pharmacology Pages: 263 - 272
Analysis of heterogeneity in daunorubicin uptake by human leukemia cells using laser flow cytometry Ram GanapathiPeter GulickRonald Bukowski Preclinical Pharmacology Pages: 273 - 277
Homoharringtonine: a phase I evaluation James A. StewartIrwin H. Krakoff Phase I and II Clinical Trials Pages: 279 - 286
Phase I evaluation of intravenous difluoromethylornithine — a polyamine inhibitor A. M. MaddoxM. J. KeatingE. J. Freireich Phase I and II Clinical Trials Pages: 287 - 292
Phase-I study of mafosfamide-cyclohexylamine (ASTA-Z-7557, NSC 345 842) and limited phase-I data on mafosfamide-lysine Uta BruntschGünther GroosWalter M. Gallmeier Phase I and II Clinical Trials Pages: 293 - 296
Phase II trial of PCNU in advanced malignant melanoma: an Eastern Cooperative Oncology Group pilot study Robert H. EarhartFranco M. MuggiaFrederick M. Golomb Phase I and II Clinical Trials Pages: 297 - 301
A phase II study of spirogermanium in patients with metastatic malignant melanoma Elizabeth EisenhauerIan KerrIan Quirt Phase I and II Clinical Trials Pages: 303 - 305
A phase II study of spirogermanium as second line therapy in patients with poor prognosis lymphoma Elizabeth EisenhauerIan QuirtJamey Skillings Phase I and II Clinical Trials Pages: 307 - 310
Phase II study of mitoxantrone in advanced squamous cell carcinoma of the head and neck Stephen D. WilliamsRobert BirchRichard Gams Phase I and II Clinical Trials Pages: 311 - 313
Acute encephalopathy associated with continuous vincristine sulfate combination therapy: case report Werner ScheithauerHeinz LudwigEva Maida Case Report Pages: 315 - 318